Routine mammograms do not reduce the incidence of late-stage breast cancer detection and may result in significant overdiagnosis of early breast cancers.
Routine mammograms do not reduce the incidence of late-stage breast cancer detection and may result in significant overdiagnosis of early breast cancers, according to a study published in the April 3 issue of Annals of Internal Medicine. Some doctors have been expressing concern that such overdiagnosis may cause unnecessary stress and medical procedures, which have risks of their own.
In 1996, Norway began a 10-year rollout of the Norwegian Breast Cancer Screening program for women ages 50 through 69. Researchers analyzed data from 39,888 women with invasive breast cancer; 7,793 had been diagnosed during the screening program. The results showed that an estimated 15 percent to 25 percent of breast cancers (1,169 to 1,948 women) were overdiagnosed.
In addition, the researchers estimated that for every 2,500 women who were invited to be screened, 2,470 to 2,474 will never be diagnosed with breast cancer and 2,499 will never die from breast cancer. On the other hand, six to 10 women will be overdiagnosed and be treated for breast cancer that may never have needed treatment to begin with.
“Mammography might not be appropriate for use in breast cancer screening because it cannot distinguish between progressive and non-progressive cancer,” said lead author Mette Kalager, a visiting scientist at Harvard School of Public Health and a researcher at the Telemark Hospital in Norway.
"Radiologists have been trained to find even the smallest of tumors in a bid to detect as many cancers as possible to be able to cure breast cancer. However, the present study adds to the increasing body of evidence that this practice has caused a problem for women - diagnosis of breast cancer that wouldn't cause symptoms or death."
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.